Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors

April 5, 2026 updated by: 5 Point App, Inc.

Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors

The purpose of the study is to evaluate whether EnergyPoints, a mobile phone health app that guides the participant to do self-acupressure, can decrease fatigue and improve sleep. Acupressure consists of applying physical pressure with fingers or a device to small locations on the body called acupoints.

  • The investigators will conduct this clinical trial remotely, allowing participants to use the app wherever they are. Participation will involve using the app daily while wearing a fitness tracker (a Fitbit) on the wrist, answering questions on the app and online, as well as completing a questionnaire and participating in an online interview at the end of the study. Participants will be assigned by chance to one of two groups. In both groups, participants will have a 1 week baseline week (Week 0) to get used to the Fitbit. Participants in the Immediate Group will start the 6 week trial of EnergyPoints immediately (Week 1). Participants in the Wait-List Group will be on a wait-list for 6 weeks during which time they will wear the Fitbit and answer online questions daily and weekly. At the end of the waiting period (week 7), these participants will begin the 6 week trial of EnergyPoints.
  • The risks to participating are minimal. There is a small risk of bruising or getting sore at a point where participants apply pressure. As with any mobile app, there is the possibility that electronic information could be viewed by third parties not involved in the study. The investigators cannot promise any benefits from participating in the study. However, it is possible that using acupressure might improve fatigue or sleep. Participants may use any other approaches to improve fatigue and sleep while in the study.

A pilot study will be conducted first with 8 participants and 1 week periods (1 week baseline, 1 week waitlist, and 1 week intervention followed by an End of Study Questionnaire and Exit Interview

Study Overview

Detailed Description

This study from 5 Point App, Inc. aims to further test EnergyPoints-an app to help cancer survivors (people living with cancer both on and off treatment) administer acupressure to self-manage cancer-related fatigue (CRF) and sleep deficiency. The study aims to validate the effectiveness of the app on clinical outcomes in a decentralized clinical trial (DCT). The expert interdisciplinary team consists of scientists and clinical experts in acupressure, symptom management, and informatics; qualitative and quantitative analysts; software engineers and marketing experts.

Up to 90% of patients receiving cancer treatment experience CRF; 30% may experience long-lasting fatigue. Sleep deficiency affects up to 75% of survivors, contributes to poor health and may exacerbate fatigue. These symptoms impact the physical, emotional, and social health of millions of cancer survivors. Exercise is most recommended for CRF, yet exercise may be difficult for some. Evidence supports benefits of other non-pharmacologic therapies (e.g., cognitive behavioral therapy-insomnia and mindfulness) for CRF and sleep disturbances, but these therapies may be unavailable, costly, or not widely adopted. Evidence supports the efficacy of acupressure to reduce fatigue (Effect size = 0.87) and improve sleep [Mean Difference (MD)= 3.72]14-19, but it is currently unfamiliar to many cancer survivors. Acupressure requires instruction by a skilled practitioner and is not covered by insurance; EnergyPoints addresses these critical barriers to adoption.

EnergyPoints app, on iOS and Android, educates and guides use of acupressure rituals to self-manage fatigue and sleep disturbances1. A follow-along format guides correct point stimulation for two acupressure rituals (stimulating and relaxing). The app synchronizes symptom self-reports with fitness tracker (e.g., an Apple Watch or Fitbit) sleep and activity data, allowing evaluation of response to acupressure. Regardless of location or access to a qualified instructor, users can self-treat and monitor symptoms and share a pdf of progress with their health care providers. The long-term goal is to improve clinical outcomes for cancer survivors by mainstreaming acupressure as a safe, affordable, self-care technique for managing symptoms. Once widely adopted, real-world-data from the app will advance science, allowing assessment of varying doses, types, and durations on effectiveness of acupressure.

During systematic user testing of EnergyPoints, cancer survivors performed acupressure as directed. Participants correctly located points and found the app easy to use; we established feasibility of connecting fitness tracker data. We added features identified by participants, such as music during the acupressure session. Participants completed at least one ritual (3 minutes per point) 87% of the time and both rituals 68% of the time. Some participants asked for "an express version." As there is no established standard for type of ritual or minimal dose of acupressure, the investigators developed a more scalable approach, allowing users to personalize their acupressure rituals to improve the experience and outcome. Users can choose rituals and timing for ½, 1, or 2 minutes per point.

The investigators will conduct a DCT in which 180 adult cancer survivors with CRF will test the EnergyPoints app at home for 6 weeks. Blocking on treatment status (on and off cancer treatment), the investigators will randomize a national, geographically, racially, and ethnically diverse sample of 180 adult cancer survivors with CRF to the EnergyPoints App-Immediate Group or a Wait-List Control Group. Data includes weekly self-report and daily app and fitness tracker measures of fatigue, sleep, and quality of life (physical and mental health). An exit interview and questionnaire will assess usability, acceptance, and desirability.

Specific Aim 1: Determine the effectiveness of EnergyPoints on clinical outcomes. The investigators will first identify key time points [baseline, start of benefit, peak of benefit] in trajectories of six weekly outcomes: fatigue, sleep, physical and mental health, total steps, and sleep efficiency. The primary analysis will then test effectiveness (Baseline to Start and Baseline to Peak, controlling for age, gender, and treatment status) by examining between- and within-subjects effects with linear mixed models in an intent-to-treat approach. The investigators will also explore the moderating effect of other personal factors and co-occurring symptoms. Milestone: Use of the app (vs. control) will clinically (MD=0.5 SD) and statistically (Group by Time interaction, p<.001) improve outcomes.

Specific Aim 2: Identify important intervention dose and enhancement effects to guide ongoing app modifications. Combining intervention data from both groups, the investigators will estimate dose and enhancement effects by analyzing interaction of time (Baseline to Peak) with intervention dose and enhancement features (e.g., dose of each ritual, time of pressing points, ritual adherence, and use of music). Milestone Significant (p<.001) interaction effects will elucidate important intervention features; effect sizes will estimate the impact.

Study Type

Interventional

Enrollment (Estimated)

180

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • New York
      • New York, New York, United States, 10011
        • Recruiting
        • 5 Point App Inc
        • Contact:
        • Contact:
        • Principal Investigator:
          • Susan L Beck, PhD
        • Principal Investigator:
          • Melanie A Gold, DO

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Have cancer or have been treated for cancer;
  • at least a moderate level of fatigue (greater than 4 on a 0 to 10 Likert-type scale);
  • able to read and speak in English;
  • age 18 years or older; Android 11 or later),
  • adequate hearing, vision, and functional ability to see, hear and use the app and participate in interviews,
  • willing to wear a provided Fitbit 24/7 (except when charging) throughout the study.

Exclusion Criteria:

  • recent history of easy bruising or bleeding
  • previous use of the EnergyPoints app.

Note: The functional ability questions will exclude anyone who is too sick to participate due to life-limiting disease.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Wait-List Control
For 6 weeks, the Wait-List control group will continue collecting data by wearing their Fitbit and completing daily and weekly surveys sent by REDCap. They will then transition to the Experimental arm for Weeks 7 through 12.
Experimental: App to guide self-acupressure
The intervention, App to guide Self-Acupressure, is delivered via a mobile health app which is used daily for 6 weeks to guide users to use self-acupressure. The dashboard provides options to tailor the rituals (stimulating and relaxing) and pressing time (½, 1 or 2 min. per point) according to symptom experience, lifestyle, and schedule. Individuals can choose to use enhancements such as aromatherapy (including an instructional safety video), relaxing music, and/or visuals during each ritual and connect with other users via the social engagement feature
The intervention is delivered via a mobile health app. EnergyPoints app, on iOS and Android, educates and guides use of acupressure rituals to self-manage fatigue and sleep disturbances. The intervention involves using the app daily for 6 weeks. A follow-along format guides correct point stimulation for two acupressure rituals (stimulating and relaxing). The app synchronizes symptom self-reports with fitness tracker (e.g., an Apple Watch or Fitbit) sleep and activity data, allowing evaluation of response to acupressure. The dashboard provides options to tailor the rituals and pressing time (½, 1 or 2 min. per point) according to symptom experience, lifestyle, and schedule. Individuals can choose to use enhancements such as aromatherapy (including an instructional safety video), relaxing music, and/or visuals during each ritual and connect with other users via the social engagement feature.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fatigue self-report 1
Time Frame: Baseline and Weekly for 7 or 13 weeks
Patient-Reported Outcome Measurement Information System (PROMIS) Fatigue 7a, a standardized measure of fatigue, yields a T score. A T score is a standardized measure on a 0 to 100 scale. The mean is 50 and SD is 10. Higher results indicate more fatigue.
Baseline and Weekly for 7 or 13 weeks
Fatigue self-report 2
Time Frame: Daily for 7 or 13 weeks
Patient Reported Outcome Measurement Information System (PROMIS) single item of fatigue intensity on a 1 to 5 scale. A higher score indicates more fatigue.
Daily for 7 or 13 weeks
Sleep Self-Report 1
Time Frame: Baseline and Weekly for 7 or 13 weeks

Patient Reported Outcome Measurement Information System (PROMIS) Sleep Disturbances 8b, a standardized measure of sleep, yields a T score.

A T score is a standardized measure on a 0 to 100 scale. The mean is 50 and SD is 10. Higher results indicate more sleep disturbance.

Baseline and Weekly for 7 or 13 weeks
Sleep Self-Report 2
Time Frame: Daily for 7 or 13 weeks
Single item measure of overall sleep quality on a scale of 1 to 5. A higher score indicates better sleep quality.
Daily for 7 or 13 weeks
Global Health
Time Frame: Baseline and Weekly for 7 or 13 weeks
Patient Reported Outcome Measurement Information System (PROMIS) Global Health V1.2.10, a standardized measure of health and functioning, includes a physical health and mental health subscale, yielding a T score for each. A T score is a standardized measure on a 0 to 100 scale. The mean is 50 and SD is 10. Higher results indicate better physical or mental health.
Baseline and Weekly for 7 or 13 weeks
Measures of Activity: Step Count
Time Frame: Daily for 7 or 13 weeks
Fitbit is worn 24/7 and data are synched via the EnergyPoints app. The measure is number of steps in a 24 hour period and the range is 0 to maximum steps.
Daily for 7 or 13 weeks
Measures of Sleep: Sleep efficiency
Time Frame: Daily for 7 or 13 weeks
Fitbit is worn 24/7 and data are synched via the EnergyPoints app. Sleep efficiency is calculated by the percent of time asleep while in bed.
Daily for 7 or 13 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Active Step Count
Time Frame: Daily for 7 or 13 weeks
Fitbit is worn 24/7 and data are synched via the EnergyPoints app. Active minutes are calculated based on achieving a certain level of activity (with an algorithm). The measure in number of active minutes per 24 hours. The range is 0 to individual's maximum.
Daily for 7 or 13 weeks
Number of Awakenings
Time Frame: Daily for 7 or 13 weeks
The Fitbit is worn 24/7 to measure activity and sleep. The number of awakenings is the number of times the participants wakes up from sleep during a 24 hour period.
Daily for 7 or 13 weeks
Total Sleep Time
Time Frame: Daily for 7 or 13 weeks
The Fitbit is worn 24/7 to measure activity and sleep. Total sleep time is the total number of minutes that the participant sleeps in 24 hours.
Daily for 7 or 13 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Susan L Beck, PhD, 5 Point App, Inc.
  • Principal Investigator: Melanie A Gold, DO, 5 Point App, Inc.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2026

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

December 19, 2024

First Submitted That Met QC Criteria

December 23, 2024

First Posted (Actual)

January 1, 2025

Study Record Updates

Last Update Posted (Actual)

April 7, 2026

Last Update Submitted That Met QC Criteria

April 5, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • R44CA297977-01 (U.S. NIH Grant/Contract: National Cancer Institute Grants.gov)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

A. Types and amount of scientific data expected to be generated in the project:

The decentralized clinical trial (DCT) will produce data from 180 cancer survivors with fatigue. There will both be quantitative and qualitative data including surveys, data synchronized from the Fitbit, and exit interview transcripts. All data will be deidentified. We will not share the software for the EnergyPoints app as it is proprietary and patented (application filed December 2023, patent pending).

IPD Sharing Time Frame

The MPIs agree to make data available within one year of the completion of the funded project period and completed publication of manuscripts pertaining to the specific aims. The duration of preservation and sharing of the data will be a minimum of 10 years after the end of the funding period. The MPIs agree to share data in a manner that is fully consistent with NIH data sharing policies and applicable laws and regulations effective at the time of grant submission.

IPD Sharing Access Criteria

All dataset(s) that can be shared will be available in Mendeley Data (a no cost repository).Mendeley Data provides searchable study-level metadata for dataset discovery. Data will be discoverable online through standard web search of the study-level metadata as well as the persistent pointer from the DOI to the dataset. Once deposited in Mendeley Data, all data will be shared in a controlled fashion to assure compliance with the approved protocol and informed consent and privacy regulations. Institutions, groups, or researchers who propose to use the DCT data are required to submit a brief proposal/data request form describing the goals and methods of the proposed analyses. Based on this document and additional discussions with the party(ies) proposing the collaboration, the decision as to whether and/or how to proceed is made by consensus between the MPIs and the 5 Point App's CEO.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer-related Problem/Condition

Clinical Trials on App to guide self-acupressure

Subscribe